483
Amneal Oncology Private LimitedAmneal Oncology Private Limited – FDA 483, Nov 17, 2023
Record Details
An FDA inspection of Amneal Oncology Private Limited in Hyderabad, India, revealed significant deficiencies in their sterile drug manufacturing operations. The firm failed to adequately investigate out-of-specification results, maintain aseptic processing controls, and validate cleaning processes and test methods. These issues indicate a lack of robust quality systems, potentially impacting the quality and safety of drug products distributed to the U.S. market.
View Company Profile
ID · 5014f0e6-2d8d-4241-810b-204ec8108fb7
Other documents for Amneal Oncology Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.